We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+5.94%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$447B
AUM Growth
+$39.1B
Cap. Flow
-$684M
Cap. Flow %
-0.15%
Top 10 Hldgs %
27.16%
Holding
15,073
New
1,965
Increased
5,545
Reduced
5,814
Closed
1,500

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$877M
2
BKNG icon
Booking.com
BKNG
+$370M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$329M
4
BA icon
Boeing
BA
+$303M
5
WMT icon
Walmart Inc
WMT
+$291M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$544M
2
MBB icon
iShares MBS ETF
MBB
+$461M
3
NVDA icon
NVIDIA
NVDA
+$452M
4
TMUS icon
T-Mobile US
TMUS
+$426M
5
AAPL icon
Apple
AAPL
+$408M

Sector Composition

Rank Sector Weight
1 Technology 3.15%
2 Healthcare 3.06%
3 Financials 2.35%
4 Consumer Discretionary 2.28%
5 Industrials 1.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTG icon
8976
PUT
MGIC Investment
MTG
$6.38B
$744K ﹤0.01%
54,700
+19,400
+55% +$279K
RVP icon
8977
PUT
Retractable Technologies
RVP
$21.6M
$743K ﹤0.01%
64,300
-8,000
-11% -$84.1K
CLDX icon
8978
CALL
Celldex Therapeutics
CLDX
$3.28B
$742K ﹤0.01%
22,200
-51,300
-70% -$1.41M
EWX icon
8979
PUT
State Street SPDR S&P Emerging Markets Small Cap ETF
EWX
$695M
$742K ﹤0.01%
12,100
-12,800
-51% -$750K
AIRG icon
8980
PUT
Airgain
AIRG
$70.9M
$740K ﹤0.01%
35,900
+20,900
+139% +$430K
QMAR icon
8981
FT Vest Growth-100 Buffer ETF March
QMAR
$584M
$740K ﹤0.01%
34,251
-194,636
-85% -$4.08M
SCSC icon
8982
Scansource
SCSC
$1.06B
$740K ﹤0.01%
26,291
-8,484
-24% -$253K
XONE
8983
DELISTED
The ExOne Company
XONE
$740K ﹤0.01%
34,190
-76,100
-69% -$1.73M
AVXL icon
8984
Anavex Life Sciences
AVXL
$297M
$739K ﹤0.01%
32,329
-6,894
-18% -$102K
DGRE icon
8985
WisdomTree Trust WisdomTree Emerging Markets Quality Dividend Growth Fund
DGRE
$146M
$739K ﹤0.01%
24,639
+391
+2% +$11.8K
FPI
8986
CALL
Farmland Partners
FPI
$434M
$739K ﹤0.01%
61,300
+27,500
+81% +$353K
PROF
8987
CALL
Profound Medical
PROF
$254M
$739K ﹤0.01%
45,200
-12,400
-22% -$231K
STGW icon
8988
Stagwell
STGW
$2.16B
$739K ﹤0.01%
+126,259
New +$590K
ACVA icon
8989
PUT
ACV Auctions
ACVA
$1.3B
$738K ﹤0.01%
+28,800
New +$839K
FYT icon
8990
First Trust Small Cap Value AlphaDEX Fund
FYT
$199M
$738K ﹤0.01%
14,495
-2,050
-12% -$106K
KOF icon
8991
Coca-Cola Femsa
KOF
$23B
$738K ﹤0.01%
13,946
-25,708
-65% -$1.27M
KAHC.WS
8992
DELISTED
KKR Acquisition Holdings I Corp. Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share
KAHC.WS
$738K ﹤0.01%
+625,000
New +$721K
HPP
8993
CALL
Hudson Pacific Properties
HPP
$752M
$737K ﹤0.01%
3,786
-271
-7% -$53.6K
MAN icon
8994
CALL
ManpowerGroup
MAN
$2.77B
$737K ﹤0.01%
6,200
-4,100
-40% -$484K
CZOO
8995
PUT
DELISTED
Cazoo Group Ltd
CZOO
$737K ﹤0.01%
37
-40
-52% -$799K
GLP icon
8996
PUT
Global Partners
GLP
$1.72B
$736K ﹤0.01%
28,400
-9,200
-24% -$226K
ALBO
8997
DELISTED
Albireo Pharma Inc
ALBO
$736K ﹤0.01%
+20,935
New +$681K
PLYA
8998
PUT
DELISTED
Playa Hotels & Resorts
PLYA
$735K ﹤0.01%
98,900
+16,500
+20% +$122K
SPRQ.WS
8999
DELISTED
Spartan Acquisition Corp. II Warrants, exercisable for one share of Class A Common Stock
SPRQ.WS
$735K ﹤0.01%
408,600
+718
+0.2% +$1.12K
CYTK icon
9000
CALL
Cytokinetics
CYTK
$10.6B
$734K ﹤0.01%
37,100
-35,000
-49% -$822K

Similar funds

Ken Griffin's Q2 2021 Portfolio in Review

As of Q2 2021, Ken Griffin held 15,073 positions worth $447B, up 9.6% from $408B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Ken Griffin's Q2 2021 filing shows 1,965 new, 5,545 increased, 5,814 reduced and 1,500 closed positions. Its largest new stake was Coinbase: 1,010,057 shares worth $256M. The largest sale was Microsoft, an estimated $544M.

By sector, the portfolio is most concentrated in Technology at 3.2% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.

  • Ken Griffin's largest Q2 2021 buy was Coinbase: 1,010,057 shares worth $256M.
  • Ken Griffin added most to AT&T in Q2 2021, an estimated $877M increase.
  • Ken Griffin's biggest Q2 2021 reduction was Microsoft, cutting an estimated $544M.
  • Ken Griffin fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $197M.
  • Ken Griffin's ten largest holdings make up 27% of its $447B portfolio in Q2 2021.
  • Ken Griffin opened 1,965 new positions and closed 1,500 in Q2 2021.
  • Ken Griffin's portfolio value rose 9.6% quarter-over-quarter to $447B.

Based on Citadel Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.